Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice

Journal of Clinical Investigation

Volumn 112, Issue 3, 2003, Pages 367-378

  Nong, Zengxuan ^a   González Navarro, Herminia ^a   Amar, Marcelo ^a   Freeman, Lita ^a   Knapper, Catherine ^a   Neufeld, Edward B ^a   Paigen, Beverly J ^b   Hoyt, Robert F ^a   Fruchart Najib, Jamila ^c   Santamarina Fojo, Silvia ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b JACKSON LABORATORY   (United States)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; LIPID; LIPOPROTEIN LIPASE; MESSENGER RNA; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTERY WALL; ARTICLE; ATHEROGENESIS; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK; RNA HYBRIDIZATION; TRANSGENIC MOUSE; ANIMAL; ARTERIOSCLEROSIS; BLOOD; C57BL MOUSE; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; FEMALE; GENE EXPRESSION; LIPASE; LIPIDS; LIPOPROTEIN LIPASE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RISK FACTORS; RNA, MESSENGER;

EID: 0041385950     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316484     Document Type: Article

References (60)

1. Olivecrona, G. and Olivecrona, T. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6:291-305.
2. Doolittle, M.H., Wong, H., Davis, R.C., and Schotz, M.C. 1987. Synthesis of hepatic lipase in liver and extrahepatic tissues. J. Lipid Res. 28:1326-1334.
3. Vieira-van Bruggen, D., et al. 1997. Hepatic lipase gene expression is transiently induced by gonadotropic hormones in rat ovaries. Mol. Cell. Endocrinol. 126:35-40.
4. Brunzell, J.D., and Deeb, S.S. 2001. Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. In The metabolic and molecular bases of inherited disease. C.R. et al., editors. McGraw-Hill. New York, New York, USA. 2789-2816.
5. Thuren, T. 2000. Hepatic lipase and HDL metabolism. Curr. Opin. Lipidol. 11:277-283.
6. 2 cholesterol. Arterioscler. Thromb. Vasc. Biol. 18:1723-1729.
7. Jansen, H., et al. 1999. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII: B: European Atherosclerosis Research Study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19:303-308.
8. Shohet, R.V., et al. 1999. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb. Vasc. Biol. 19:1975-1978.
9. Couture, P., et al. 2000. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 20:815-822.
10. Cohen, J.C., Vega, G.L., and Grundy, S.M. 1999. Hepatic lipase: new insights from genetic and metabolic studies. Curr. Opin. Lipidol. 10:259-267.
11. Campos, H., Dreon, D.M., and Krauss, R.M. 1995. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J. Lipid Res. 36:462-472.
12. Beisiegel, U. 1996. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis. 124:1-8.
13. Santamarina-Fojo, S., Haudenschild, C., and Amar, M. 1998. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 9:211-219.
14. Dugi, K.A., et al. 2000. In vivo evidence for both lipolytic and non-lipolytic function of hepatic lipase in the metabolism of high density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 20:793-800.
15. Amar, M.J.A., et al. 1998. Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE deficient mice. J. Lipid Res. 39:2436-2442.
16. Dichek, H.L., et al. 2001. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice. J. Lipid Res. 42:201-210.
17. Zambon, A., Deeb, S.S., Bensadoun, A., Foster, K.E., and Brunzell, J.D. 2000. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J. Lipid Res. 41:2094-2099.
18. Dugi, K.A., et al. 2001. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 104:3057-3062.
19. Hokanson, J.E., et al. 2002. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes. 51:1208-1213.
20. 2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12:814-823.
21. Zambon, A., Deeb, S.S., Brown, B.G., Hokanson, J.E., and Brunzell, J.D. 2001. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation. 103:792-798.
22. Fan, J., et al. 1994. Overexpression of heparic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 91:8724-8728.
23. Busch, S.J., et al. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269:16376-16382.
24. Mezdour, H., Jones, R., Dengremont, C., Castro, G., and Maeda, N. 1997. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 272:13570-13575.
25. Bergeron, N., et al. 1998. Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. Proc. Natl. Acad. Sci. U. S. A. 95:15647-15652.
26. Homanics, G.E., et al. 1995. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270:2974-2980.
27. Zhang, S.H., Reddick, R.L., Piedrahita, J.A., and Maeda, N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
28. Vaisman, B.L., et al. 1995. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270:12269-12275.
29. Berard, A.M., et al. 1997. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin cholesteryl acyltransferase. Nat. Med. 3:744-749.
30. Gonzalez-Navarro, H., et al. 2002. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J. Lipid Res. 43:671-675.
31. Babaev, V.R., Patel, M.B., Semenkovich, C.F., Fazio, S., and Linton, M.F. 2000. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem. 34:26293-26299.
32. Iverius, P.-H., and Brunzell, J.D. 1985. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am. J. Physiol. 249:E107-E114.
33. Sullivan, P.M., et al. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272:17972-17980.
34. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D., and Williams, R.A. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231-240.
35. Linton, M.F., and Fazio, S. 1999. Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies. Curr. Opin. Lipidol. 10:97-105.
36. Curtiss, L.K., and Boisvert, W.A. 2000. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 11:243-251.
37. Krall, W.J., Challita, P.M., Perlmutter, L.S., Skelton, D.C., and Kohn, D.B. 1994. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood. 83:2737-2748.
38. Kennedy, D.W., and Abkowitz, J.L. 1997. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood. 90:986-993.
39. Schiller, N.K., Kubo, N., Boisvert, W.A., and Curtiss, L.K. 2001. Effect of γ-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:1674.
40. Bamberger, M., Glick, J.M., and Rothblat, G.H. 1983. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J. Lipid Res. 24:869-876.
41. Auwerx, J.H., Marzetta, C.A., Hokanson, J.E., and Brunzel, J.D. 1989. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 9:319-325.
42. Choi, S.Y., Komaromy, M.C., Chen, J., Fong, L.G., and Cooper, A.D. 1994. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J. Lipid Res. 35:848-859.
43. Aviram, M., Bierman, E.L., and Chait, A. 1988. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 263:15416-15422.
44. Yagyu, H., et al. 1999. Overexpression of lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J. Lipid Res. 40:1677-1685.
45. Lessner, S.M., Prado, H.L., Waller, E.K., and Galis, Z.S. 2002. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 160:2145-2155.
46. van Furth, R. 1970. Origin and kinetics of monocytes and macrophages. Semin. Hematol. 7:125-141.
47. Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L., and Ross, R. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14:133-140
48. Vaisman, B.L., et al. 2001. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J. Clin. Invest. 108:303-309. doi:10.1172/JCI200112517.
49. Babaev, V.R., et al. 1999. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103:1697-1705.
50. Peterson, J., Bengtsson-Olivecrona, G., and Olivecrona, T. 1986. Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochim. Biophys. Acta. 878:65-70.
51. Lee, S.H., Starkey, P.M., and Gordon, S. 1985. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161:475-489.
52. Lindqvist, P., Ostlund-Lindqvist, A.M., Witztum, J.L., Steinberg, D., and Little, J.A. 1983. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J. Biol. Chem. 258:9086-9092.
53. Wang, X., Greilberger, J., and Jurgens, G. 2000. Calcium and lipoprotein lipase synergistically enhance the binding and uptake of native and oxidized LDL in mouse peritoneal macrophages. Atherosclerosis. 150:357-363.
54. Rumsey, S.C., Obunike, J.C., Arad, Y., Deckelbaum, R.J., and Goldberg, I.J. 1992. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 90:1504-1512.
55. Saxena, U., Kulkarni, N.M., Ferguson, E., and Newtou, R.S. 1992. Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells. Biochem. Biophys. Res. Commun. 189:1653-1658.
56. Auerbach, B.J., et al. 1999. Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix. Atherosclerosis. 142:89-96.
57. Tabas, I., et al. 1993. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268:20419-20432.
58. Saxena, U., Klein, M.G., Vanni, T.M., and Goldberg, I.J. 1992. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J. Clin. Invest. 89:373-380.
59. Auerbach, B.J., Bisgaier, C.L., Wolle, J., and Saxena, U. 1996. Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix. J. Biol. Chem. 271:1329-1335.
60. Saxena, U., Ferguson, E., Auerbach, B.J., and Bisgaier, C.L. 1993. Lipoprotein lipase facilitates very low density lipoprotein binding to the subendothelial cell matrix. Biochem. Biophys. Res. Comm. 194:769-774.